These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8914623)
1. Differential effect of peroxisome proliferators on rat glutathione S-transferase isoenzymes. Voskoboinik I; Drew R; Ahokas JT Toxicol Lett; 1996 Oct; 87(2-3):147-55. PubMed ID: 8914623 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferators increase the formation of BPDE-DNA adducts in isolated rat hepatocytes. Voskoboinik I; Ooi SG; Drew R; Ahokas JT Toxicology; 1997 Sep; 122(1-2):81-91. PubMed ID: 9274804 [TBL] [Abstract][Full Text] [Related]
3. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872 [TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells. Voskoboinik I; Drew R; Ahokas JT Chem Biol Interact; 1997 Jul; 105(2):81-97. PubMed ID: 9251722 [TBL] [Abstract][Full Text] [Related]
5. In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators. Tomaszewski KE; Agarwal DK; Melnick RL Carcinogenesis; 1986 Nov; 7(11):1871-6. PubMed ID: 3769136 [TBL] [Abstract][Full Text] [Related]
6. Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase, and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Rao MS; Nemali MR; Usuda N; Scarpelli DG; Makino T; Pitot HC; Reddy JK Cancer Res; 1988 Sep; 48(17):4919-25. PubMed ID: 2457433 [TBL] [Abstract][Full Text] [Related]
7. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures. Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome proliferator, in male F-344 rats. Hayashi F; Tamura H; Yamada J; Kasai H; Suga T Carcinogenesis; 1994 Oct; 15(10):2215-9. PubMed ID: 7955056 [TBL] [Abstract][Full Text] [Related]
9. Effects of peroxisome proliferators and/or hypothyroidism on xenobiotic-metabolizing enzymes in rat testis. Mehrotra K; Morgenstern R; Lundqvist G; Becedas L; Bengtsson Ahlberg M; Georgellis A Chem Biol Interact; 1997 May; 104(2-3):131-45. PubMed ID: 9212780 [TBL] [Abstract][Full Text] [Related]
10. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin. Abdellatif AG; Préat V; Vamecq J; Nilsson R; Roberfroid M Carcinogenesis; 1990 Nov; 11(11):1899-902. PubMed ID: 2225320 [TBL] [Abstract][Full Text] [Related]
12. Long-term effects of hypolipidemic peroxisome proliferator administration on hepatic hydrogen peroxide metabolism in rats. Tamura H; Iida T; Watanabe T; Suga T Carcinogenesis; 1990 Mar; 11(3):445-50. PubMed ID: 2311188 [TBL] [Abstract][Full Text] [Related]
13. Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by autoradiography. Cattley RC; Richardson KK; Smith-Oliver T; Popp JA; Butterworth BE Cancer Lett; 1986 Dec; 33(3):269-77. PubMed ID: 3802057 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferation and resistance to hydrogen peroxide in rat hepatocytes: is development of resistance an adaptation to cytotoxicity? Garberg P; Stenius U; Nilsson K; Högberg J Carcinogenesis; 1992 Oct; 13(10):1751-8. PubMed ID: 1423834 [TBL] [Abstract][Full Text] [Related]
15. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats. Lake BG; Gray TJ; Körösi SA; Walters DG Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403 [TBL] [Abstract][Full Text] [Related]
16. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. Conway JG; Tomaszewski KE; Olson MJ; Cattley RC; Marsman DS; Popp JA Carcinogenesis; 1989 Mar; 10(3):513-9. PubMed ID: 2924396 [TBL] [Abstract][Full Text] [Related]
17. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS; Cattley RC; Conway JG; Popp JA Cancer Res; 1988 Dec; 48(23):6739-44. PubMed ID: 3180084 [TBL] [Abstract][Full Text] [Related]
18. The effects of peroxisome proliferators on protein abundances in mouse liver. Anderson NL; Esquer-Blasco R; Richardson F; Foxworthy P; Eacho P Toxicol Appl Pharmacol; 1996 Mar; 137(1):75-89. PubMed ID: 8607144 [TBL] [Abstract][Full Text] [Related]
19. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Melnick RL Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753 [TBL] [Abstract][Full Text] [Related]
20. Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Hasmall SC; James NH; Macdonald N; Soames AR; Roberts RA Arch Toxicol; 2000 Apr; 74(2):85-91. PubMed ID: 10839475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]